Long-term study indicates no calcification with CardioCel after eight years
22, August, 2016
Long-term data from a Phase II extension study for the repair of congenital heart defects in paediatrics using CardioCel shows that all patients continue to progress well, with no sign of calcification or need for repeat procedures.
Admedus shares rise on hospital infusion pump supply deal with Arcomed
25, May, 2016
Admedus said today it won a supply contract with the new Royal Adelaide Hospital for the installation of the Arcomed chroma infusion pump systems. The supply tender includes ongoing technical and clinical support as well as consumable products for the systems over the next 5 years.
Admedus Wins 2016 Australian Manufacturer of the Year Award
14, May, 2016
After triumphing in the Most Innovative category, Admedus also took out the night’s biggest award ‘Manufacturer of the Year’. In August 2014 Admedus opened its state-of-the-art bio-manufacturing facility in Malaga, WA, and has experienced huge success in exporting its bio-scaffold regenerative medicine product, CardioCel, since then.
Gardasil creator is testing a DNA vaccine to wipe out cancer-causing HPV virus
1, March, 2016
Professor Ian Frazer (the creator of Gardasil) is working with healthcare company Admedus to create a DNA vaccine which could be injected in people who already have HPV to stop it progressing to cervical cancer. Admedus Chief Scientific Officer Dr David Rhodes said the technology developed by Admedus in conjunction with Frazer could potentially be applied to a […]
Performance and versatility of a new tissue engineered collagen scaffold in cardiovascular surgery
24, February, 2016
Professor Leon Neethling was published in the February 2016 edition of Pädiatrische Kardiologie (German Pediatric Cardiology) journal where he discussed the performance and versatility of CardioCel in cardiovascular surgery. First publication: Lebendige Wissenschaft, Spitzenforschung Pädiatrische Kardiologie 2016; 96-466:46-47 Posted here with kind permission of Alpha Informationsgesellschaft mbH, Germany
Admedus inks exclusive distro deal with Coroneo
27, January, 2016
Admedus (ASX:AHZ) has inked an exclusive distribution agreement with Coroneo to sell its extra aortic annuloplasty ring and other heart valve surgery instruments in Germany and the U.K.
Admedus HSV-2 vaccine set for key value inflection point
22, September, 2015
In an interview with leading online biotech site, BioTuesdays, Chief Operating Officer Julian Chick discusses Admedus’ anticipated interim results from a Phase 2 trial of its therapeutic vaccine for the treatment of herpes simplex virus-2 (HSV-2).